Highlights

  • Suplilab is a high-quality ATIC provider with a leading position in food and medical device testing.
  • The Costa Rican market is experiencing rapid growth in demand for Risk-based Quality Assurance services.
  • The acquisition gives Intertek immediate access to ATIC growth opportunities in Central America.

Intertek Group plc (LSE:ITRK), a global provider of Total Quality Assurance services, has announced the acquisition of Suplilab, a leading testing company based in San José, Costa Rica. The move expands Intertek’s footprint in Central America, providing access to a rapidly growing market for food safety and medical device testing. The acquisition positions Intertek to meet rising demand for Risk-based Quality Assurance (ATIC) services in the region.

Strategic Expansion into Central America

Intertek’s acquisition of Suplilab enables the Group to expand its ATIC (Assurance, Testing, Inspection, and Certification) presence in Central America.

Suplilab has built a reputation in Costa Rica for technical expertise in microbiology, water testing, and chemistry analysis. The company employs 38 skilled professionals and reported revenues of £3.1 million in 2024. Suplilab has demonstrated rapid growth in high-margin sectors, making it a leading provider in both food safety and medical device testing.

Growing Demand for Quality Assurance in Costa Rica

Costa Rica’s fast-growing economy is driving demand for Risk-based Quality Assurance solutions. Consumers are seeking safer, more sustainable food options, while the medical device sector continues to expand.

Immediate Access to Growth Opportunities

The acquisition provides Intertek with a foothold in Central America, opening up further opportunities for ATIC services across the region. Suplilab’s existing client base and reputation in high-growth markets offer Intertek a platform for expanding its reach and service offerings.

André Lacroix, Chief Executive Officer of Intertek, said: "The acquisition of Suplilab in Costa Rica is an exciting opportunity to enter into Central America's high-growth, high-margin food and medical devices spaces, deepening our industry-leading ATIC footprint in Latin America. We look forward to working with the Suplilab team to seize the exciting growth opportunities ahead."

ITRK shares were trading at GBX 5,075.00 per share at the time of writing on 3 November 2025.